Skip to main content
. 2018 Oct 22;14(1):1535747. doi: 10.1080/19932820.2018.1535747

Table 2.

Interstitial glucose variability during CGM recording.

  Pre-Ramadan
(non-fasting)
Early-Ramadan
(fasting)
P Late-Ramadan
(fasting)
P Post-Ramadan
(non-fasting)
P
MAGE All (n = 33) 54 (26–120) 70 (33–146) 0.007 67 (30–124) ns 65 (35–144) ns
Male (n = 24)
Female
58.5 (34–120)
52 (26–113)
75.5 (37–146)
66 (33–80)
0.008
ns
71 (30–114)
60 (40–124)
ns
ns
57 (35–144)
80 (38–135)
ns
ns
≤2 ADM
>2 ADM
46 (26–120)
69 (40–113)
58 (33–123)
81.5 (53–146)
ns
0.027
55 (30–114)
76 (36–124)
ns
ns
65 (35–136)
69.5 (41–144)
ns
ns
On SU (n = 13)
No SU
69 (33–120)
46 (26–111)
86.5 (60–146)
58 (33–96)
0.009
ns
83 (40–124)
61 (30–103)
ns
ns
84 (51–144)
53 (35–136)
ns
ns
CV 0.18 (0.12–0.41) 0.20 (0.10–0.34) ns 0.20 (0.13–0.30) ns 0.21 (0.12–0.28) ns
TIR (%) 92 (39–100) 93 (51–100) ns 92 (15–100) ns 91 (08–100) ns
TIHyper (%) 6 (0–61) 7 (0–49) ns 6 (0–85) ns 8 (0–92) ns
TIHypo (%) 0 (0–20) 0 (0–8) ns 0 (0–8) ns 0 (0–9) ns

Data are shown in median (range). P = P-value vs. pre-Ramadan. MAGE = mean amplitude of glucose excursions, ADM = anti-diabetic medication, SU = sulphonylurea, CV = coefficient of variation, TIR = time in range (70–180 mg/dl), TIHyper = time in hyperglycemia.

(>180 mg/dl), TIHypo = time in hypoglycaemia (< 70mg/dl).